February 4, 2025
February 4, 2025
India – Navigating ESG Compliance: Lessons From Recent Trends And The Santos Case.
- Faraz Alam Sagar - Cyril Amarchand Mangaldas,
February 4, 2025
India – Scope Of Summoning Indian Nationals For Virtual Testimonies By Securities And Exchange Commission- Legal Limits By Local Laws And International Cooperation Framework.
- Faraz Alam Sagar - Cyril Amarchand Mangaldas,
January 28, 2025
India – The Importance Of Brand Strategy And Management For Large Family Businesses.
- Swati Sharma - Cyril Amarchand Mangaldas,
January 28, 2025
India – After Sunset: Courts On Post Rohan Builders.
January 21, 2025
India – Mergers And Acquisitions In The Indian Insurance Broking Space.
- Indranath Bishnu - Cyril Amamrchand Mangaldas, Cyril Amamrchand Mangaldas
January 21, 2025
India – FIG Paper (No. 40 – Data Law Series 6) Draft Digital Personal Data Protection Rules, 2025 – Key Implications For Financial Services Sector.
- Anu Tiwari - Cyril Amarchand Mangaldas,
January 21, 2025
India – Fig Paper (No. 41 – VDA Series 4) Global Crypto Developments: Lessons For India’s Regulatory Regime In 2025..
- Anu Tiwari - Cyril Amarchand Mangaldas,
January 14, 2025
Public Takeovers In India: Flashback 2024.
- Cyril S. Shroff - Cyril Amarchand Mangaldas,
January 14, 2025
India – Scope Of Interrogatories In Patent Infringement Suits: The Delhi High Court Reiterates The “Necessity Test”.
- Swati Sharma - Cyril Amarchand Mangaldas,
January 7, 2025
India – Inventions Addressing Transaction Security Patentable Under Indian Patents Act.
- Swati Sharma - Cyril Amarchand Mangaldas,
December 24, 2024
Legal Spotlight On Ads: Changing Flavor Of Ad-laws In India.
December 24, 2024
India – Crypto Sales Prior To AY 2022–23: Taxable As Capital Gains?
December 17, 2024
Calcutta Joins The Ranks: Addition Of Another IP Division In India’s Legal Landscape.
- Swati Sharma - Cyril Amarchand Mangaldas,
December 17, 2024
India – Is It Acceptable To File Divisional Application On The Day Of Grant Of Parent Application?
- Swati Sharma - Cyril Amarchand Mangaldas,
December 10, 2024
India – Cure Or Supplement – Overlap Between Drugs And Nutraceuticals.
December 10, 2024
India – SEBI’s Proposed New Amendments On Usage Of AI Tools By Regulated Entities.
- Anu Tiwari - Cyril Amarchand Mangaldas,
December 3, 2024